Novartis

GSK Chief Says UK “Better in EU”

Drug Firms Urge Governments to Fight Superbugs

Recipharm in Ophthalmic Collaboration with Alcon

Roche Wins Patent Dispute Against Cipla

Pfizer to Buy Allergan for $160 Billion

Novartis to Settle With US on Kickback Charges

Topics • Technology

Chances and Hurdles for Biosimilars

Topics • Strategy

Leaving the Patent Cliff Behind

Topics • Strategy

Pharma Players Mostly Lift 2015 Guidance

Topics • Strategy

Significant Value Creation

Novartis and Amgen Partner on Alzheimer’s and Migraine

Novartis Buys Rights to Multiple Sclerosis Drug from GlaxoSmithKline

Aveo Licenses Antibody to Novartis for Treatment of Cachexia

Novartis Can Sell Neupogen Copy in US in September

Novartis Buying US Biotech Company for $200 Million

Perrigo Buying GSK, Novartis Consumer Brands

GSK Chief Witty Questions Pharma M&A Economics

Mylan Said to Prepare Poison Pill Potion Against Teva

Novartis Boosts Cancer Immunotherapy Research Efforts

FDA Approves the First-Ever US Biosimilar

Topics • Strategy

Drugs Industry Battered by Currency and Competition

Arrowhead Buys Novartis’ RNAi R&D Portfolio

Novartis Gets Green Light to Buy GSK Cancer Drugs

Drug Majors’ Venture Capital Funds Back Genetics Start-up

EC Approves Novartis-GSK Asset Swap With Strings

GSK Chief Sees More Unit IPOs as Options

German Watchdog Says Eylea No Better Than Lucentis

Bayer Fails to Block Cancer Generic in India

Novartis’s Gilenya Fails on Primary Progressive MS

Germany's Merck Plans to Expand in Consumer Health

Bayer Closes $14.2 Billion Buy of Merck & Co OTC

Lucentis and Avastin Said to Have Similar Side Effects

New Novartis Heart Drug Seen to Have Enormous Potential

Topics • Strategy

M&A in Chemicals & Pharmaceuticals

German Doctors Stand by MS Drugs Despite Warning

158 more articles

Top-Feature

Concept Heidelberg

ECA Foundation Aims to Become Largest Pharma Association for GMP/GDP Compliance

Easyfairs Deutschland GmbH

Leading the way. Driving results.

BIO Deutschland e.V.

German Biotech Days 2026: Biotechnology as The Key to Industrial Competitiveness

Nova-Institut GmbH

Advanced Recycling Conference 2025: New Paths to the Circular Economy

Brenntag Downsizes Management Board, Retains Both Divisions

Bio-Rad Laboratories

Dual‑Targeting Breakthroughs: Advancements in Bispecific Antibody Development

JMP Statistical Discovery / SAS Institute GmbH

From Data to Decisions: Digital Tools Reshaping the Chemical and Life Sciences Landscape

Leading Transformation

Dow Chemical Company

Anchored in Sustainability

CHEManager International c/o Wiley-VCH GmbH

API Manufacturing

CHEManager c/o Wiley-VCH Verlag

Upcoming Virtual Events

Interview

Driving Sustainability Through Collaboration

Building Green Practices Across the Chemical Supply Chain

Driving Sustainability Through Collaboration

Together for Sustainability (TfS) is a pioneering, member-led initiative working to accelerate sustainable and resilient chemical supply chains. TfS President Jennifer Jewson discusses the origins of TfS, its evolving goals, its present-day challenges, and the initiative’s enduring impact and outlook for the future.